You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博雅生物(300294.SZ):擬與交易對方江西百聖、上海懿仁簽署協議 以保障已支付股權轉讓款資金安全及能夠按時歸還公司
格隆匯 05-18 12:40

格隆匯5月18日丨博雅生物(300294.SZ)公佈,公司於2020年4月20日召開第六屆董事會第三十二次會議,審議通過了《關於終止發行股份、可轉換公司債券購買資產的議案》,公司董事會決定終止發行股份、可轉換公司債券購買無錫羅益(無錫)生物製藥有限公司(“羅益生物”)48.87%股權事項,詳見公司2020年4月20日在巨潮資訊網披露的《關於終止發行股份、可轉換公司債券購買資產的公告》。公司董事會決定終止收購羅益生物股權事項後,公司積極與本次重組交易對方溝通,落實收回已支付的股權轉讓款等後續事項。

2020年5月17日,經公司第六屆董事會第三十四次會議,審議通過了《關於簽署價款返還<協議>的議案》,公司擬與交易對方江西百聖管理諮詢有限公司、上海懿仁投資合夥企業(有限合夥)分別簽署《協議》,以保障公司已支付的股權轉讓款資金安全及能夠按時歸還公司。

截至目前,公司江西百聖管理諮詢有限公司的羅益股權項目款項7675萬元,上海懿仁投資合夥企業(有限合夥)的羅益股權項目款項5709萬元,總計13,384萬元。公司與交易對方江西百聖管理諮詢有限公司、上海懿仁投資合夥企業(有限合夥)分別簽署《協議並安排股權質押作為擔保措施,以保障公司已付的股權轉讓款資金安全及能夠按時歸還公司,該事項不會對公司生產經營產生重大影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account